Trends in Survival of Patients With Uterine Serous Carcinoma From 1988 to 2011: A Population-Based Study.
作者： Haider Mahdi , Xiaozhen Han , Laura Moulton , Roberto Vargas , None
DOI: 10.1097/IGC.0000000000001007
关键词:
摘要: Objective Our study used the Surveillance, Epidemiology, and End Result database to determine if changes in treatment paradigm observed over last 2 decades have improved outcomes patients with uterine serous carcinoma (USC). Methods Women USC were identified using from 1988 2011 (n = 8230) grouped into 3 cohorts (1988–1997, 1998–2004, 2005–2011). Disease-specific survival overall estimated. Kaplan-Meier curves Cox regression models used. Results (59 vs 94 months not reached; P Conclusions Changes trends for resulted an improvement outcome especially those stage I–III disease.
sci-hub.se 参考文章(38)
Gregory Sutton, Janice H. Axelrod, Brian N. Bundy, Tapan Roy, Howard D. Homesley, John H. Malfetano, Borys R. Mychalczak, Mary E. King, Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: A gynecologic oncology group study Gynecologic Oncology. ,vol. 97, pp. 755- 763 ,(2005) , 10.1016/J.YGYNO.2005.03.011
M.G. Kelly, D. O'Malley, P. Hui, J. McAlpine, J. Dziura, T.J. Rutherford, M. Azodi, S.K. Chambers, P.E. Schwartz, Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Gynecologic Oncology. ,vol. 95, pp. 469- 473 ,(2004) , 10.1016/J.YGYNO.2004.08.030
Chia-Yen Huang, Yun-Hsin Tang, Ying-Cheng Chiang, Kung-Liahng Wang, Hung-Chun Fu, Yu-Min Ke, Hei-Yu Lau, Keng-Fu Hsu, Ching-Hu Wu, Wen-Fang Cheng, Impact of management on the prognosis of pure uterine papillary serous cancer - A Taiwanese Gynecologic Oncology Group (TGOG) study Gynecologic Oncology. ,vol. 133, pp. 221- 228 ,(2014) , 10.1016/J.YGYNO.2014.02.010
Holly H. Gallion, Virginia L. Brunetto, Michael Cibull, Samuel S. Lentz, Gary Reid, John T. Soper, Robert A. Burger, Willie Andersen, Randomized Phase III Trial of Standard Timed Doxorubicin Plus Cisplatin Versus Circadian Timed Doxorubicin Plus Cisplatin in Stage III and IV or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study Journal of Clinical Oncology. ,vol. 21, pp. 3808- 3813 ,(2003) , 10.1200/JCO.2003.10.083
Padma Mallipeddi, Nelson N. H. Teng, Daniel S. Kapp, Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma Cancer. ,vol. 71, pp. 3076- 3081 ,(1993) , 10.1002/1097-0142(19930515)71:10<3076::AID-CNCR2820711030>3.0.CO;2-Z
Amanda Nickles Fader, Richard D. Drake, David M. O'Malley, Heidi E. Gibbons, Warner K. Huh, Laura J. Havrilesky, Paola A. Gehrig, Erin Tuller, Allison E. Axtell, Kristine M. Zanotti, , Platinum/taxane‐based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma Cancer. ,vol. 115, pp. 2119- 2127 ,(2009) , 10.1002/CNCR.24247
David I. Shalowitz, Alexandra M. Vinograd, Robert L. Giuntoli, Geographic access to gynecologic cancer care in the United States Gynecologic Oncology. ,vol. 138, pp. 115- 120 ,(2015) , 10.1016/J.YGYNO.2015.04.025
Michael Hendrickson, Jon Ross, Patricia Eifel, Alvaro Martinez, Richard Kempson, Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. The American Journal of Surgical Pathology. ,vol. 6, pp. 93- 108 ,(1982) , 10.1097/00000478-198203000-00002
Alvaro A Martinez, Sheldon Weiner, Karl Podratz, Ali-Reza Armin, Jannifer S Stromberg, Robert Stanhope, Alfred Sherman, Mark Schray, Donald A Brabbins, Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation. Gynecologic Oncology. ,vol. 90, pp. 537- 546 ,(2003) , 10.1016/S0090-8258(03)00199-9
Larissa J. Lee, Rebecca DeMaria, Ross Berkowitz, Ursula Matulonis, Akila N. Viswanathan, Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen Gynecologic Oncology. ,vol. 132, pp. 65- 69 ,(2014) , 10.1016/J.YGYNO.2013.10.035